SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-13-288738
Filing Date
2013-07-12
Accepted
2013-07-12 06:06:43
Documents
4
Period of Report
2013-08-22
Effectiveness Date
2013-07-12

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT d552495ddef14a.htm DEF 14A 699545
2 GRAPHIC g552495g23l62.jpg GRAPHIC 226230
3 GRAPHIC g552495g65q13.jpg GRAPHIC 202250
4 GRAPHIC g552495g75h03.jpg GRAPHIC 21785
  Complete submission text file 0001193125-13-288738.txt   1321703
Mailing Address 951 BROKEN SOUND PARKWAY NW SUITE 320 BOCA RATON FL 33487
Business Address 951 BROKEN SOUND PARKWAY NW SUITE 320 BOCA RATON FL 33487 561-961-1911
TherapeuticsMD, Inc. (Filer) CIK: 0000025743 (see all company filings)

IRS No.: 870233535 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-00100 | Film No.: 13964956
SIC: 2834 Pharmaceutical Preparations